Re: FDA (b)anality

Subject: Re: FDA (b)anality
From: Paul Goble <pgcommunication -at- gmail -dot- com>
To: TECHWR-L <techwr-l -at- lists -dot- techwr-l -dot- com>
Date: Thu, 12 Jan 2012 13:06:36 -0600

Would it be acceptable to include the official notice in a less-prominent
place, then in a more prominent place include a notice which would actually
be meaningful to the reader?

I haven't yet worked on FDA-regulated medical devices, so I'm curious. It
probably isn't critical in this case, but I can imagine circumstances where
using only the official wording could in fact place the user or patient in

Paul Goble

Create and publish documentation through multiple channels with Doc-To-Help.
Choose your authoring formats and get any output you may need. Try
Doc-To-Help, now with MS SharePoint integration, free for 30-days.

You are currently subscribed to TECHWR-L as archive -at- web -dot- techwr-l -dot- com -dot-

To unsubscribe send a blank email to
techwr-l-leave -at- lists -dot- techwr-l -dot- com
or visit

To subscribe, send a blank email to techwr-l-join -at- lists -dot- techwr-l -dot- com

Send administrative questions to admin -at- techwr-l -dot- com -dot- Visit for more resources and info.

Looking for articles on Technical Communications? Head over to our online magazine at

Looking for the archived Techwr-l email discussions? Search our public email archives @


FDA (b)anality: From: Chris Morton
Re: FDA (b)anality: From: Milan Davidović

Previous by Author: Re: Another Punctuation Question
Next by Author: RE: Question about duplicate Search text boxes in Flare Web Help
Previous by Thread: Re: FDA (b)anality
Next by Thread: RE: FDA (b)anality

What this post helpful? Share it with friends and colleagues:

Sponsored Ads